Cannell & Spears’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-77,712
| Closed | -$14.9M | – | 258 |
|
|
2019
Q4 | $14.9M | Sell |
77,712
-32,812
| -30% | -$6.27M | 1.59% | 23 |
|
|
2019
Q3 | $18.6M | Sell |
110,524
-7,139
| -6% | -$1.2M | 2.16% | 21 |
|
|
2019
Q2 | $19.7M | Sell |
117,663
-2,494
| -2% | -$418K | 2.31% | 21 |
|
|
2019
Q1 | $17.6M | Buy |
120,157
+675
| +0.6% | +$98.8K | 2.24% | 22 |
|
|
2018
Q4 | $16M | Sell |
119,482
-11,305
| -9% | -$1.51M | 2.34% | 20 |
|
|
2018
Q3 | $24.9M | Buy |
130,787
+4,787
| +4% | +$912K | 2.98% | 13 |
|
|
2018
Q2 | $21M | Buy |
126,000
+25,243
| +25% | +$4.21M | 2.73% | 19 |
|
|
2018
Q1 | $17M | Buy |
100,757
+6,901
| +7% | +$1.16M | 2.21% | 21 |
|
|
2017
Q4 | $15.4M | Sell |
93,856
-8,518
| -8% | -$1.39M | 1.87% | 22 |
|
|
2017
Q3 | $21M | Buy |
102,374
+4,625
| +5% | +$948K | 2.51% | 20 |
|
|
2017
Q2 | $23.8M | Sell |
97,749
-4,107
| -4% | -$998K | 2.95% | 17 |
|
|
2017
Q1 | $24.3M | Buy |
101,856
+202
| +0.2% | +$48.3K | 3.08% | 16 |
|
|
2016
Q4 | $21.3M | Sell |
101,654
-37,121
| -27% | -$7.8M | 2.74% | 18 |
|
|
2016
Q3 | $32M | Sell |
138,775
-11,074
| -7% | -$2.55M | 4.02% | 10 |
|
|
2016
Q2 | $34.6M | Buy |
149,849
+32,092
| +27% | +$7.42M | 4.39% | 8 |
|
|
2016
Q1 | $31.6M | Sell |
117,757
-681
| -0.6% | -$183K | 3.85% | 12 |
|
|
2015
Q4 | $37M | Buy |
118,438
+31,438
| +36% | +$9.82M | 4.23% | 8 |
|
|
2015
Q3 | $23.6M | Buy |
87,000
+1,574
| +2% | +$428K | 2.7% | 21 |
|
|
2015
Q2 | $25.9M | Buy |
+85,426
| New | +$25.9M | 2.87% | 17 |
|